Photo of Chiung-Yu Chen

View Scopus Profile

Chiung-Yu Chen

Associate Professor

  • 1304 Citations
  • 19 h-Index
1993 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 私立中山醫學院醫學系學士

Research Interests

  • 胃腸肝膽疾病

Fingerprint Dive into the research topics where Chiung-Yu Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles
Bile Medicine & Life Sciences
Gallstones Medicine & Life Sciences
Liver Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Bile Ducts Medicine & Life Sciences
Cholangiocarcinoma Medicine & Life Sciences
Stomach Medicine & Life Sciences
Hemorrhage Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2012

一氧化碳在膽汁鬱滯肝疾病之利膽及保肝作用

Chen, C.

11-08-01 → 12-07-31

Project: Research project

一氧化碳對膽汁分泌的影響-從生理至病態生理研究

Chen, C.

10-08-01 → 11-07-31

Project: Research project

內質網壓力與血質氧化酉每-1於膽汁淤塞性肝傷害中之角色

Chen, C.

08-08-01 → 09-07-31

Project: Research project

以蛋白質體學探討氧化壓力及氮化壓力於膽道阻塞引起肝臟傷害之角色

Chen, C.

06-08-01 → 07-07-31

Project: Research project

功能性蛋白質體於膽汁的應用 – 著重於氧化壓力及氮化相關之蛋白質檢測

Chen, C.

05-08-01 → 06-07-31

Project: Research project

Research Output 1993 2019

Combined transarterial embolization/ chemoembolization-based locoregional treatment with sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: A propensity score matching study

Chien, S. C., Chen, C-Y., Cheng, P-N., Liu, Y. S., Cheng, H-C., Chuang, C-H., Chang, T-T., Chiu, H. C., Lin, Y-J. & Chiu, Y-C., 2019 Jan 1, In : Liver Cancer. 8, 3, p. 186-202 17 p.

Research output: Contribution to journal › Article

Propensity Score
Hepatocellular Carcinoma
Survival
Liver
Liver Neoplasms
1 Citation (Scopus)

Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment a digestive endoscopy society of tawian (dest)

Chung, C. S., Tsai, C. L., Chu, Y. Y., Chen, K. C., Lin, J. C., Chen, B. C., Sun, W. C., Yen, H. H., Chen, C-Y., Wu, I. C., Kuo, C. H., Shih, H. Y., Bair, M. J., Wang, J. P., Hu, W. H., Yang, C. S., Han, M. L., Cheng, T. Y., Tseng, C. M., Tsai, M. C. & 2 others, Hu, M. L. & Wang, H. P., 2018 Sep 1, In : Medicine (United States). 97, 38, e12101.

Research output: Contribution to journal › Article

Neuroendocrine Tumors
Endoscopy
Stomach
Neoplasm Metastasis
Therapeutics
1 Citation (Scopus)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during longterm entecavir therapy

Lin, T-C., Chiu, Y-C., Chiu, H-C., Liu, W. C., Cheng, P-N., Chen, C-Y., Chang, T-T. & Wu, I-C., 2018 Feb 14, In : World journal of gastroenterology. 24, 6, p. 725-736 12 p.

Research output: Contribution to journal › Article

Chronic Hepatitis B
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Therapeutics
entecavir
1 Citation (Scopus)

Bile acid profiles in neonatal intrahepatic cholestasis caused by citrin deficiency

Yang, C. H., Chen, C-Y., Chou, Y-Y., Chiu, H-C., Tsai, W. L. & Shiesh, S-C., 2017 Dec 1, In : Clinica Chimica Acta. 475, p. 28-35 8 p.

Research output: Contribution to journal › Article

Bile Acids and Salts
Plasmas
Neonatal-onset citrullinemia type 2
citrin
Citrullinemia
6 Citations (Scopus)

Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma

Lee, T. Y., Lin, C. C., Chen, C-Y., Wang, T. E., Lo, G. H., Chang, C. S. & Chao, Y., 2017 Sep 1, In : Medicine (United States). 96, 37, e7655.

Research output: Contribution to journal › Article

Hepatocellular Carcinoma
Survival
Confidence Intervals
Taiwan
Neoplasms